Dakhlaoui, I.; Bernard, P.J.; Pietrzak, D.; Simakov, A.; Maj, M.; Refouvelet, B.; Béduneau, A.; Cornu, R.; Jozwiak, K.; Chabchoub, F.;
et al. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment. Int. J. Mol. Sci. 2023, 24, 9742.
https://doi.org/10.3390/ijms24119742
AMA Style
Dakhlaoui I, Bernard PJ, Pietrzak D, Simakov A, Maj M, Refouvelet B, Béduneau A, Cornu R, Jozwiak K, Chabchoub F,
et al. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences. 2023; 24(11):9742.
https://doi.org/10.3390/ijms24119742
Chicago/Turabian Style
Dakhlaoui, Imen, Paul J. Bernard, Diana Pietrzak, Alexey Simakov, Maciej Maj, Bernard Refouvelet, Arnaud Béduneau, Raphaël Cornu, Krzysztof Jozwiak, Fakher Chabchoub,
and et al. 2023. "Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment" International Journal of Molecular Sciences 24, no. 11: 9742.
https://doi.org/10.3390/ijms24119742
APA Style
Dakhlaoui, I., Bernard, P. J., Pietrzak, D., Simakov, A., Maj, M., Refouvelet, B., Béduneau, A., Cornu, R., Jozwiak, K., Chabchoub, F., Iriepa, I., Martin, H., Marco-Contelles, J., & Ismaili, L.
(2023). Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences, 24(11), 9742.
https://doi.org/10.3390/ijms24119742
